Related Experiment Video
Updated: May 13, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Cognitive impairment in multiple sclerosis: a forgotten disability remembered
Cerebrum : the Dana Forum on Brain Science
|March 1, 2013
Summary
Cognitive impairment affects up to 65% of multiple sclerosis (MS) patients, impacting memory. Current drug trials have failed, but new diagnostic and therapeutic strategies offer future hope for MS cognitive dysfunction.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Cognitive impairment in multiple sclerosis (MS) was recognized over 160 years ago.
- A standardized cognitive function test was developed only in 2001.
- Up to 65% of individuals with MS experience cognitive impairment, primarily affecting memory.
Purpose of the Study:
- To review the historical context and current understanding of cognitive impairment in MS.
- To discuss the challenges and failures in developing treatments for MS-related cognitive dysfunction.
- To highlight the need for novel approaches in diagnosis and drug development for MS cognitive impairment.
Main Methods:
- Historical review of clinical observations and diagnostic tool development.
- Analysis of current prevalence and impact of cognitive impairment in MS.
- Summary of outcomes from pharmaceutical trials targeting MS cognitive impairment.
Main Results:
- Cognitive impairment is a prevalent issue in MS, significantly impacting memory.
- Existing therapeutic strategies and drug trials have not yet yielded successful treatments.
- Despite setbacks, research continues to explore new avenues for managing MS cognitive deficits.
Conclusions:
- Effective treatments for cognitive impairment in MS are still lacking.
- Optimism remains for future therapies through innovative diagnostic and drug development approaches.
- Further research is essential to address the unmet needs of MS patients with cognitive dysfunction.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Language and Cognition
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
01:29Intellectual Disability
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:25Learning Disabilities
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...